Home » Posts tagged with » PricewaterhousseCoopers

VC in biotechnology drops in second quarter

Venture capital funding in biotechnology and medical device industries decreased 39 percent during the second quarter of 2012, according to a PricewaterhouseCoopers report, “Dollar Drought.” The VC investment equaled $1.4 billion, the lowest level since the fourth quarter of 2010. Deal volume was also down, dropping 6 percent from earlier this year to 174 deals.… Continue Reading VC in biotechnology drops in second quarter